Safety and early efficacy analysis of a novel combination of the PARP inhibitor veliparib (ABT-888) plus bendamustine and rituximab in patients with lymphoma Meeting Abstract
| Authors: | Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Moskowitz, C. H.; Noy, A.; Portlock, C. S.; Palomba, M. L.; Straus, D. J.; Younes, A.; Zelenetz, A. D.; Chen, A.; Little, R. F.; Fallon, F.; Whang, J. H. |
| Abstract Title: | Safety and early efficacy analysis of a novel combination of the PARP inhibitor veliparib (ABT-888) plus bendamustine and rituximab in patients with lymphoma |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349242704065 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.1739.1739 |
| Notes: | Meeting Abstract: 1739 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
